Trump Administration’s Drug Strategy Is at Odds with Recent Actions on Funding, Policy
The 195-page federal roadmap warns of psychosis, cancer and pediatric poisonings, while saying little about methamphetamine or marijuana rescheduling.
3 Articles
3 Articles
Trump administration’s drug strategy is at odds with recent actions on funding, policy
The White House’s new strategy for addressing the nation’s drug crisis calls for a number of consensus public health measures: the overdose-reversal medication naloxone, medication-assisted treatment, and test strips used to detect fentanyl or other drug supply adulterants. But the May 4 document appears to run counter to many of the Trump administration’s latest drug policy actions. In particular, it comes just days after the administration is…
2026 National Drug Control Strategy Is Very Concerned About Marijuana
The Office of National Drug Control Policy (ONDCP) has released the 2026 National Drug Control Strategy, the first one under President Donald Trump’s second term. Though the wide-ranging federal roadmap to “defeat the scourge of illicit drugs” devotes a lot of space to nitazenes, kratom, 7-OH and other relatively recent additions to the supply, the biggest threat the ONDCP wants the public to know about seems to be marijuana. Though the 2026 Str…
The new U.S. National Drug Control Strategy for 2026 establishes a zero-tolerance policy for impunity in the region, prioritizing Mexico and Colombia as the areas of greatest concern for the production and trafficking of synthetic drugs. This 195-page document formalizes a maximum-pressure stance that conditions international cooperation on the delivery of immediate results in four key areas: increased arrests, expedited extraditions, the destru…
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
